7Baggers
 Why Ascendis Pharma Stocks Are Gaining Attention  TipRanks Mon, 17 Nov 2025 15:12:32 GMT
 Growth Stocks To Research - November 14th  MarketBeat Sun, 16 Nov 2025 20:55:09 GMT
 Published on: 2025-11-16 02:33:36  newser.com Sun, 16 Nov 2025 08:33:36 GMT
 behavioral patterns of asnd and institutional flows  news.stocktradersdaily.com Sat, 15 Nov 2025 19:56:01 GMT
 Promising Growth Stocks To Consider - November 13th  MarketBeat Fri, 14 Nov 2025 21:29:46 GMT
 Ascendis Pharma Shares Surge Amid Strong Revenue Growth  TipRanks Fri, 14 Nov 2025 16:24:16 GMT
 Published on: 2025-11-14 12:37:43  Fundação Cultural do Pará Fri, 14 Nov 2025 15:37:43 GMT
 ascendis pharma a/s (nasdaq:asnd) q3 2025 earnings call transcript  Insider Monkey Fri, 14 Nov 2025 13:13:02 GMT
 Ascendis Pharma A/S: Strong Growth and Strategic Challenges  TipRanks Fri, 14 Nov 2025 00:32:47 GMT
 Goldman Sachs maintains Ascendis Pharma stock rating despite Yorvipath sales miss  Investing.com Canada Fri, 14 Nov 2025 00:05:16 GMT
 Ascendis Pharma’s Stunning Leap Forward  StocksToTrade Thu, 13 Nov 2025 21:03:00 GMT
 Ascendis Pharma: Q3 Earnings Review (NASDAQ:ASND)  Seeking Alpha Thu, 13 Nov 2025 19:30:02 GMT
 Ascendis Pharma stock maintains Overweight rating at Cantor Fitzgerald  Investing.com Thu, 13 Nov 2025 12:50:42 GMT
 ascendis pharma grants 41,220 employee warrants at $201.16 per share by investing.com  Investing.com Australia Thu, 13 Nov 2025 11:50:45 GMT
 Ascendis Pharma AS (ASND) Q3 2025 Earnings Call Highlights: Stro  GuruFocus Thu, 13 Nov 2025 05:10:45 GMT
 Ascendis Pharma Reports Strong Q3 2025 Performance  TipRanks Thu, 13 Nov 2025 04:17:34 GMT
 Ascendis Pharma AS earnings missed by €0.72, revenue topped estimates  Investing.com Nigeria Thu, 13 Nov 2025 00:49:37 GMT
 Earnings call transcript: Ascendis Pharma misses Q3 2025 EPS forecast  Investing.com Wed, 12 Nov 2025 23:56:01 GMT
 ascendis pharma a/s q3 2025 earnings report  MarketBeat Wed, 12 Nov 2025 23:37:30 GMT
 Ascendis Pharma Grants Warrants to Employees in Strategic Move  TipRanks Wed, 12 Nov 2025 22:25:53 GMT
 Why Ascendis Pharma Shares Are Under Pressure  TipRanks Wed, 12 Nov 2025 21:56:26 GMT
 Ascendis Pharma grants 41,220 employee warrants at $201.16 per share  Investing.com Wed, 12 Nov 2025 21:52:52 GMT
 ascendis pharma shares tumble as q3 earnings miss overshadows revenue beat  Investing.com Nigeria Wed, 12 Nov 2025 21:24:59 GMT
 Ascendis Pharma Reports Third Quarter 2025 Financial Results  GlobeNewswire Wed, 12 Nov 2025 21:01:00 GMT
 Ascendis Pharma Q3 2025 Earnings Preview  MSN Wed, 12 Nov 2025 02:27:38 GMT
 are these 4 biotech stocks set to beat q3 earnings estimates?  Yahoo Finance Mon, 10 Nov 2025 16:21:00 GMT
 ascendis pharma (asnd) reports positive long-term findings for t  GuruFocus Fri, 07 Nov 2025 14:28:22 GMT
 ascendis pharma announces new pooled analysis on transcon pth  TipRanks Fri, 07 Nov 2025 14:02:06 GMT
 new pooled 3-year analysis confirms sustained, clinically  GlobeNewswire Fri, 07 Nov 2025 13:30:00 GMT
 published on: 2025-11-05 07:32:13  newser.com Wed, 05 Nov 2025 13:32:13 GMT
 (asnd) movement within algorithmic entry frameworks  news.stocktradersdaily.com Tue, 04 Nov 2025 18:40:02 GMT
 biotech stocks facing fda decision in november 2025  Nasdaq Sat, 01 Nov 2025 02:06:00 GMT
 published on: 2025-11-05 00:53:56  newser.com Fri, 31 Oct 2025 10:43:32 GMT
 published on: 2025-10-31 04:36:02  newser.com Fri, 31 Oct 2025 09:36:02 GMT
 published on: 2025-10-31 02:07:36  newser.com Fri, 31 Oct 2025 07:07:36 GMT

Ascendis Pharma
(NASDAQ:ASND) 

ASND stock logo

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and Tran...

Founded: 2006
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends